COVID-19 Trials in ryazan, russia
Conditions / COVID-19 / ryazan, russia
Research into COVID-19 spans multiple therapeutic approaches and trial phases.
13 total trials for this combination
Showing top 10 of 13 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05601167 | Open Multicentre Study of the Safety and Efficacy Against COVID-19 of Nirmatrelvir/Ritonavir in the Adult Population | COMPLETED | PHASE3 |
| NCT04467840 | Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia | COMPLETED | PHASE2/PHASE3 |
| NCT05595824 | Open Multicenter Study for Assessment of Efficacy and Safety of Molnupiravir in Adult Patients With COVID-19 | COMPLETED | PHASE3 |
| NCT05185804 | Clinical Trial of Dimolegin (DD217) in Prevention of Thrombotic Complications in Patients With COVID-19 | COMPLETED | PHASE3 |
| NCT04335136 | Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19 | COMPLETED | PHASE2 |
| NCT04434248 | An Adaptive Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19 | UNKNOWN | PHASE2/PHASE3 |
| NCT04623021 | A Study Evaluating the Efficacy and Safety of CKD-314 (Nafabelltan) in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia | COMPLETED | PHASE2 |
| NCT04842435 | Clinical Study in the Treatment of Patients With Moderate Course of COVID-19 | UNKNOWN | PHASE2/PHASE3 |
| NCT04542694 | Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19 | COMPLETED | PHASE3 |
| NCT05216497 | Efficacy and Safety of Ingavirin®, 90 mg Capsules in Patients With COVID-19 | COMPLETED | PHASE3 |